A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(36 sites)

United States

Sylvester Comprehensive Cancer Center, Miami, Florida

Florida Cancer Specialists, Sarasota, Florida

The Emory Clinic, Atlanta, Georgia

Northwestern University, Chicago, Illinois

Dana-Farber Cancer Institute, Boston, Massachusetts